You have requested access to member-only content.
Review highlights from the 2024 OPPS final rule and 340B remedy plan
The 2024 OPPS final rule details changes to price transparency compliance, reimbursement changes and, updates to numerous other hospital programs. Additionally, CMS is moving forward with its proposals to address unlawful payment reductions to 340B drug reimbursement.
This is an excerpt from member-only content. Please log in or become a member.
Log in to access this content:
Unable to log in?
Click here to reset your password or unlock your account.
Forgot your username?
Contact customer care at customerservice@hcpro.com or call 800-650-6787, between 8 AM - 5 PM CT
Not a member? Join now!
Revenue Cycle Advisor is the key to your organization's Medicare regulatory news and education. It combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule updates thoroughly.
For questions and support, please call customer service: 800-650-6787.
Try before you buy with our FREE samples!